3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
23
Multiple Myeloma
9
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Glioma
8
Thyroid Neoplasms
7
Neoplasm Metastasis
7
Hematologic Neoplasms
6
Thyroid Carcinoma, Anaplastic
5
Lymphoma
5
Thyroid Cancer, Papillary
4
Pancreatic Neoplasms
4
Neurofibromatosis 1
4
Neoplasms
4
Lung Neoplasms
3
Brain Neoplasms
3
Astrocytoma
3
Adenocarcinoma, Follicular
3
Skin Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neurofibroma, Plexiform
2
Leukemia, Myelomonocytic, Juvenile
2
Histiocytosis, Langerhans-Cell
2
Glioblastoma
2
Colonic Neoplasms
2
Advanced Solid Tumors
2
Uveal Melanoma
1
Interventions
Injections
6
pembrolizumab
5
toripalimab
3
tislelizumab
3
senaparib
3
Bevacizumab
3
sintilimab
2
Technetium
2
Specimen Handling
2
Nivolumab
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Blood Specimen Collection
2
zimberelimab
1
tumor-cells apoptosis factor, human
1
tazemetostat
1
spartalizumab
1
sacituzumab govitecan
1
rucaparib
1
osimertinib
1
olaparib
1
etoposide phosphate
1
enzalutamide
1
envafolimab
1
cemiplimab
1
cedazuridine
1
atezolizumab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
trametinib
×
1 year
×
Clear all
No trials found.